# RIVIVE
> **NDA217722** · New Drug Application · Sponsor: HARM REDUCTION THERP · Approved 2023-07-28
## Drug
- **FDA Application Number:** NDA217722
- **Application type:** New Drug Application
- **Brand name:** RIVIVE
- **Generic name:** NALOXONE HYDROCHLORIDE
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HARM REDUCTION THERP
- **Manufacturer:** Harm Reduction Therapeutics, Inc.
- **First approval:** 2023-07-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217722)
---
*AI Analytics · CC0 1.0*